Study of the effect of Anagliptin administration on the activity of glucagon after test meal loading - Study of the effect of Anagliptin administration on the activity of glucagon after test meal loading

Arc Cardiovascular Clinic0 个研究点目标入组 20 人开始时间: 2016年3月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with a history of hypersensitivity to the components of Anagliptin 2) Patients with severe ketosis, diabetic coma or pre-coma, or type I diabetes mellitus 3) Patients with severe infection or severe trauma, and pre- or post-operative patients 4) Patients with severe renal impairment or on dialysis with end-stage renal failure 5) Patients with a history of abdominal surgery (limited to gastrointestinal surgery) or intestinal obstruction 6) Women who are currently pregnant or may be pregnant, or women who are currently breastfeeding 7) Patients who are currently on continual insulin preparations or have been determined to require insulin preparations 8) Patients who are currently using GLP-1 receptor agonist medication or have been determined to require GLP-1 receptor agonist medication 9) Patients who may have allergy to wheat or eggs 10) Patients who may have difficulty conducting the test meal loading (no alcohol the previous day, 10 hours fasting, etc.) 11) Patients determined to be unsuitable for participation in the study by the research investigators or sub-investigators

发起方

Arc Cardiovascular Clinic